✦ LIBER ✦

Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation

✍ Scribed by A.A.M.J. Hollander; J.L.C.M. van Saase; L.A. van Es; F.J. van derWoude; H.J. van Bockel; J.L.C.M. van Saase; A.M.M. Kootte; W.T. van Dorp

Book ID: 118557560
Publisher: The Lancet
Year: 1995
Tongue: English
Weight: 666 KB
Volume: 345
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(95)90520-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion from cyclosporin to azathiopr

Conversion from cyclosporin to azathioprine after kidney transplantation

✍ Florian Kronenberg; Alfred Königsrainer; Karl Lhotta; Raimund Margreiter; Hans D 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 448 KB

Beneficial effects of conversion from cy

Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients

✍ M.A van den Dorpel; M Levi; J.N IJzermans; J.W ten Cate; W Weimar 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Successful conversion from tacrolimus to

Successful conversion from tacrolimus to cyclosporine after kidney transplantation

✍ J Yashima; I Koyama; H Ishida; T Sawada; T Tojimbara; I Nakajima; S Fuchinoue; T 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Elective conversion from cyclosporine to

Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation

✍ Thistlethwaite, J.Richard; Haag, Brian W.; Jones, Kenneth W.; Stuart, Joan K.; S 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 554 KB

Conversion from cyclosporine A to azathi

Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients

✍ van den Dorpel, Marinus A; Ghanem, Hosam; Rischen-Vos, Jacqueline; Man In't Veld 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 550 KB

Post-transplant conversion from cyclospo

Post-transplant conversion from cyclosporin to azathioprine: effect on cardiovascular risk profile

✍ F. Sutherland; E. Burgess; J. Klassen; S. Buckle; L. C. Paul 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 420 KB

The benefits of long-term cyclosporin (CyA) therapy are not yet established and must be weighed against its toxicity. We studied cardiovascular risk factors in 25 patients who received a kidney transplant between 1985 and 1989 and in whom CyA was discontinued. The protocol for discontinuing CyA invo